This 50 minute three-part webinar contrasts the transvenous ICDs to the novel subcutaneous ICD with regards to patient screening, surgical implant technique, and post - operative concerns.
This activity is centered around heart rhythm management and implantable device management.
WASHINGTON, DC — The U.S. Food and Drug Administration, in collaboration with major implantable pacemaker and ICD manufacturers, demonstrated the effects of emissions from radio frequency identification (RFID) readers on common implantable cardiac devices. According to research published in the January edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, the observed effects may cause increasing complications as RFID use expands in the medical device field.
WASHINGTON, DC — March 1, 2010 – Analysis of ICD patients enrolled in four different trials found patients with life-threatening ventricular arrhythmias (VA) treated only with antitachycardia pacing (ATP) have higher survival rates than VA patients who experienced at least one shock-treated episode. According to research published in the March edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, 80.2% of VA episodes were successfully treated with ATP-only therapy from an ICD.
WASHINGTON, July 1, 2010 — New large meta-analysis from five primary prevention randomized implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of Sudden Cardiac Death (SCD) on overall mortality in women. According to research published in the July edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, women in primary prevention ICD trials have the same overall mortality as men, while experiencing significantly less appropriate ICD interventions. With more than 1,600 women, this meta-analysis includes the largest cohort of women to date.
Lack of awareness and treatment of sudden cardiac arrest (SCA) puts African Americans at greater risk of death from the condition, according to a new national survey released today by the Heart Rhythm Society (HRS). The survey findings uncovered significant perception gaps between healthcare providers and consumers when it comes to understanding the condition, its symptoms, risk factors and treatments. Responsible for more than 350,000 U.S. deaths each year, SCA occurs when the heart suddenly and unexpectedly stops beating. Approximately 95 percent of SCA cases result in death; however, it is proven most deadly in African Americans.
ICD Shock Reduction: Update on Economic Impact and Therapeutic Options
Join key opinion leaders Bruce Wilkoff, MD, FHRS and Mintu Turakhia, MD, MS, FHRS, with moderator, Thomas Deering, MD, FHRS for a fast-paced 30-minute Learn from the Experts Webinar on this developing topic
The meeting will present current and future management on sudden cardiac death, new drug and ablation treatment for atrial fibrillation, pacing and ICD advances, cardiac resynchronization techniques, remote patient monitoring, and advances in neuromodulation for heart failure and hypertension. The well received certificate Cardiac Rhythm Management Course will continue, and new courses on EPS/ECG added.
WASHINGTON, DC — New research reveals that abandoning a nonfunctioning lead in an ICD patient is safe and does not pose a clinically significant risk of complication. The lead is the wire placed in the heart that transmits the heart's electrical signals to the defibrillator for interpretation. The new study published in the January edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society, suggests that the practice of abandoning nonfunctioning leads does not result in additional risk to the patient and lead extraction should be reserved for cases of system infection or when large numbers of leads have been abandoned.
This program will include separate sessions on atrial fibrillation and heart failure management with an emphasis on the use of CRT as well as a focus on therapies for bradycardia (pacemakers) and tachycardia (ICD).
Defibrillation, or shock, can be the only way to stop certain heart arrhythmias, or irregular heartbeats, before they kill. If the heart beats too quickly, the chambers, or ventricles, will not have enough time to fill with blood and pump blood to the rest of the body, which can cause death. For people at high risk for the deadliest forms of arrhythmias – called ventricular tachycardia and ventricular fibrillation – an internal “shocking” device may be the best protection against sudden cardiac arrest (SCA).